New approaches to the assessment and classification of patient's selection parameters for phase II-III clinical trials
https://doi.org/10.21886/2712-8156-2023-4-3-76-86
Abstract
Objective: to study the rate of enrollment of patients for inclusion in clinical trial according to various parameters and its change under the influence of internal factors, to develop new parameters and indicators that could be sensitive for assessing the effect of the this factors.
Materials and methods: a retrospective analysis of phase II-III data from four phase II-III clinical trials in the field of oncology and hematology conducted from 2007 to 2017.
Results: the rate of recruitment of patients, other parameters of recruitment of patients and their derivatives, which were influenced by internal factors, were studied.
Conclusions: Patient recruitment is affected by internal factors. This impact can be multidirectional: can increase the number of patients or, conversely, reduce it. Knowing the direction of the influence of a certain factor, it is possible to predict the success of both the recruitment of patients and the success of the clinical trial in general.
About the Author
S. S. Milovanov
SE Milovanov Svyatoslav Sergeevich
Russian Federation
Russian Federation
Milovanov Svyatoslav S. – Cand. Sci. (Med.), independent researcher; IP Milovanov Svyatoslav Sergeevich
Moscow
References
1. Chin Feman P., L.T. Nguyen, M.T. Quilty, C.E. Kerr, B.H. Nam, L.A. Conboy, J.P. Singer, M. Park, A. Lembo, T.J. Kaptchuk, R.B. Davis, Effectiveness of recruitment in clinical trials: an analysis of methods used in a trial for irritable bowel syndrome patients, Contemp. Clin. Trials 29 (2008) 241–251
2. Fogel David B. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review // Contemporary Clinical Trials Communications 11 (2018) 156–164
3. Rutger M. van den Bora, Diederick E. Grobbeea,b, Bas J. Oostermana, Petrus W.J. Vaessena, Kit C.B. Roesb Predicting enrollment performance of investigational centers in phase III multi-center clinical trials // Contemporary Clinical Trials Communications 7 (2017) p.208–216
4. Kibby M. Patient recruitment feasibility. // Applied Clinical Trails, Volume 20, Number 6, June 2011. P. 80-87
5. Fouad M.N., J.Y. Lee, P.J. Catalano, T.M. Vogt, S.Y. Zafar, D.W. West, C. Simon, C.E. Klabunde, K.L. Kahn, J.C. Weeks, C.I. Kiefe, Enrollment of patients with lung and colorectal cancers onto clinical trials, J. Oncol. Pract. 9 (2) (2013) e40–47, https://doi.org/10.1200/JOP.2012.000598.
6. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-2726, 2004
7. Stewart JH, Bertoni AG, Staten JL, et al: Participation in surgical oncology clinical trials: Gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328-3334, 2007
8. Du W, Gadgeel SM, Simon MS: Predictors of enrollment in lung cancer clinical trials. Cancer 106:420-425, 2006
9. Nass SJ, Moses HL, Mendelsohjn J (eds): A National Cancer Clinical Trials System for the 21st Century. Washington, DC, National Academies Press, 2010
10. The Thomson Corporation Annual Report 2004. Access https://core.ac.uk/download/pdf/33158412.pdf. 124 p. last access 21 Jul 2021
11. Bienkowski Robert S and Norman M. Goldfarb. Screen Failures in Clinical Trials: Financial Roulette or the Cost of Doing Business? // Journal of clinical research best practices. Vol. 4, No. 7, July 2008. https://www.magiworld.org/Journal/2008/0807_Screen_Failures.pdf
12. Bachenheimer, J. F. (2004, April), “Good recruitment practice: Working to create the bond between study and subject,” Applied Clinical Trials, 13 (4), 56–59
13. Bachenheimer Joan F. and Bonnie A. Brescia, Reinventing Patient Recruitment: Revolutionary Ideas for Clinical Trial Success, (Gower Publishing, Surrey, UK, 2007).
14. Wooden Karen, John C. Shneider. The CRA’s guide to monitoring clinical research. 2003. Thomson, 467 p
15. Myles, P.S., Williamson, E., Oakley, J. et al. Ethical and scientific considerations for patient enrollment into concurrent clinical trials. Trials 15, 470 (2014). https://doi.org/10.1186/1745-6215-15-470
Supplementary files
Review
For citations:
Milovanov S.S. New approaches to the assessment and classification of patient's selection parameters for phase II-III clinical trials. South Russian Journal of Therapeutic Practice. 2023;4(3):76-86. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-3-76-86
Views:
430
Email this article 